REQUEST A DEMO
Total
USD $0.00
Search more companies

Parabolic Drugs Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Parabolic Drugs Ltd. Profile Updated: February 14, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English Download a sample report

Parabolic Drugs Limited engages in the manufacture and contract manufacture of active pharmaceutical ingredients (API) and API intermediates. The company offers semi synthetic penicillin and cephalosporin range of antibiotics in oral and sterile forms, as well as provides Ceftazidime, Cefotiam, Ceftizoxime, and Cephalothin. Parabolic Drugs serves pharmaceutical companies in South East Asia, North America, Latin America, Brazil, the Middle East, North Africa, and parts of East and South Africa. The company was founded in 1996 and is based in Punjab.

Legal Address
S.C.O. 186-187,, 2nd floor, Sector 8C
Chandigarh; Punjab; Postal Code: 160017

Contact Details: Purchase the Parabolic Drugs Ltd. report to view the information.

Website: http://www.parabolicdrugs.com

Basic Information
Total Employees:
Purchase the Parabolic Drugs Ltd. report to view the information.
Outstanding Shares:
Purchase the Parabolic Drugs Ltd. report to view the information.
Registered Capital:
Purchase the Parabolic Drugs Ltd. report to view the information.
Financial Auditors:
Purchase the Parabolic Drugs Ltd. report to view the information.
Incorporation Date:
1996
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
43.43%
Purchase this report to view the information.
37.06%
Purchase this report to view the information.
10.14%
Purchase this report to view the information.
8.06%
Purchase this report to view the information.
0.73%
Subsidiaries
Parabolic Research Labs Ltd.
100%
Ziven Lifesciences Ltd.
100%
Company Performance
Financial values in the chart are available after Parabolic Drugs Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
57.77%
EBITDA
83.14%
Net Profit (Loss) for the Period
60.09%
Total equity
0%
Return on Equity (ROE)
31.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?